lidocaine has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies
Lidocaine: A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE.
lidocaine : The monocarboxylic acid amide resulting from the formal condensation of N,N-diethylglycine with 2,6-dimethylaniline.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Chen, JL | 1 |
Liu, ST | 1 |
Huang, SM | 1 |
Wu, ZF | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Long-term Outcomes of Breast Cancer Patients Receiving Levobupivacaine Wound Infiltration or Diclofenac for Postoperative Pain Relief[NCT05829707] | Phase 4 | 120 participants (Actual) | Interventional | 2009-01-05 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 other study available for lidocaine and ER-Negative PR-Negative HER2-Negative Breast Cancer
Article | Year |
---|---|
Apoptosis, Proliferation, and Autophagy Are Involved in Local Anesthetic-Induced Cytotoxicity of Human Breast Cancer Cells.
Topics: Anesthetics, Local; Apoptosis; Autophagy; Cell Line, Tumor; Cell Proliferation; Doxorubicin; Female; | 2022 |